Effects of nintedanib use in patients with pneumoconiosis: potential for accelerated aging

Pneumoconiosis is a chronic lung disease caused by long-term inhalation of mineral dust. It is mainly characterized by fibrosis of lung tissue and decreased respiratory function. With the continuous development of medical research, Nintedanib (Nintedanib), as a tyrosine kinase inhibitor, is widely used to treat idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Although nintedanib has shown positive effects in slowing the progression of pulmonary fibrosis, there is currently a lack of clear scientific evidence on whether it accelerates aging in patients with pneumoconiosis.

The main role of nintedanib is to inhibit biological processes related to fibrosis, thereby slowing the progression of lung damage. Due to continuous exposure to harmful dust, patients with pneumoconiosis often experience varying degrees of fibrosis in their lung tissue. By using nintedanib, these patients are able to reduce the rate of pulmonary fibrosis to a certain extent, thereby improving quality of life and survival. Therefore, from this perspective, the use of nintedanib will not directly lead to accelerated aging, but may delay the pathological changes related to pneumoconiosis to a certain extent.

Nintedanib has been approved by the U.S. Food and Drug Administration (FDA) and is one of the two leading drugs for the treatment of idiopathic pulmonary fibrosis. Although the efficacy of nintedanib has been confirmed by multiple clinical trials, most of the subjects were elderly people. In this context, the impact of aging on the efficacy of nintedanib is difficult to clearly discern from existing clinical data due to the presence of multiple confounding variables such as genetics, gender, comorbidities, and disease stage.

Clinical studies have shown that nintedanib may cause a range of adverse events, such as diarrhea, nausea and weight loss. If these side effects are not effectively managed, they may affect the patient's overall health and even lead to a decline in physiological functions and a deterioration in quality of life. However, it is not appropriate to directly link these adverse reactions with "accelerated aging" because aging is a complex biological process that is jointly affected by multiple factors such as genetics, environment and lifestyle.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613836/